久久久国产一区二区_欧美在线小视频_高清一区二区三区_久久综合久久久_成人久久久久久久久_亚洲精品视

上海非利加實業有限公司Logo

熱門詞: 進口電動溫度調節閥結構圖|進口電動溫度調節閥數據表進口電動高溫調節閥-德國進口電動高溫法蘭調節閥進口電動蒸汽調節閥-德國進口電動蒸汽調節閥

當前位置: 首頁 > 所有品牌 > Psivida
Psivida
Psivida Psivida

美國Psivida  
pSivida是一個發展中的小型化,注射,藥物輸送系統的領導。我們開發產品,以治療嚴重或危及生命的疾病,單獨或與其他公司合作。我們已經開發出的設備是如此之小,他們是FDA批準進入眼內的管理,一旦管理他們釋放其藥物的幾個月甚至幾年。

pSivida is a leader in the development of miniaturized, injectable, drug delivery systems. We develop products to treat serious or life threatening diseases alone or in partnership with other companies. We have developed devices that are so small they are FDA approved to be administered into the eye and once administered they release their drug for months and years.
pSivida's lead development product, ILUVIEN?, delivers fluocinolone acetonide (FA). It is designed to be injected into the eye to provide sustained release into the back of the eye for up to three years after a single injection. ILUVIEN has completed two three-year Phase III clinical trials in Diabetic Macular Edema, one of the leading causes of blindness in the developed world. The NDA was submitted to the FDA in May 2011 by our licensee Alimera Sciences and the review is expected to be completed by the end of 2011. ILUVIEN is also in Phase II clinical trials in dry age-related macular degeneration, wet age-related macular degeneration and retinal vein occlusion. These studies are being conducted by Alimera Sciences.
pSivida's two FDA approved sustained release products to treat chronic back of the eye diseases are Retisert? for the treatment of posterior uveitis and Vitrasert? for the treatment of AIDS-related cytomegalovirus (CMV) retinitis. pSivida has licensed both of these products and the technologies underlying them to Bausch & Lomb Incorporated. Vitrasert and Retisert provide sustained release for six to nine months and two and a half years, respectively.
pSivida has a world wide collaborative Research and Development agreement with Pfizer Inc. to develop a long term sustained release implant to deliver latanoprost for patients with ocular hypertension and glaucoma. This collaboration is focused on developing a bioerodible version of pSivida's proprietary Durasert? technology designed to be injected into the subconjunctival space of the eye.
pSivida is developing a series of additional miniaturized, bioerodible sustained release technologies to deliver a range of proteins and small drug molecules to virtually any site in the body. One of these technologies is Tethadur?, a nanostructured bioerodible material.
pSivida's intellectual property portfolio consists of 180 patents either issued or granted for acceptance, over 150 pending applications and 60 patent families.

關于我們客戶服務產品分類法律聲明
主站蜘蛛池模板: 99热成人精品免费久久 | 亚洲最新在线 | 一区二区三区高清不卡 | 黄色毛片免费观看 | 伊人久久影院 | 国产不卡一区二区视频免费 | 亚欧成人毛片一区二区三区四区 | 欧美午夜视频在线 | 最新亚洲精品 | 成人看的一级毛片 | 久久亚洲一级α片 | 日韩欧美一区二区三区不卡在线 | 特级一级全黄毛片免费 | 欧美日韩免费一区二区三区 | 日韩亚洲欧美在线爱色 | 久久一区二区精品综合 | 欧美视频三区 | 国产精品色综合久久 | 国精产品一区 | 国产区精品福利在线社区 | 国产成人一区二区三区视频免费蜜 | 国产a级一级久久毛片 | 国产免费看视频 | 欧美日韩国产乱了伦 | 亚洲人成一区 | 亚洲天码中文字幕第一页 | 日韩电影中文字幕在线网站 | 欧美日韩91 | 国产欧美综合精品一区二区 | 一级大毛片 | 欧美日韩综合精品一区二区三区 | 欧美日韩国产在线播放 | 精品欧美一区二区三区在线 | 精品国产网站 | 欧美激情综合亚洲一二区 | 免费一区二区三区在线视频 | 中文字幕亚洲综合 | 精品国产一区二区三区久久影院 | 亚洲国产日韩欧美在线as乱码 | 欧美日韩在线观看视频 | 免费观看a黄一级视频 |